VINC
Vincerx Pharma, Inc. Common Stock
VINC
VINC
Delisted
VINC was delisted on the 22nd of April, 2025.
36 hedge funds and large institutions have $13.3M invested in Vincerx Pharma, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
Holders
36
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$146K | |
| 2 | +$60K | |
| 3 | +$28.2K | |
| 4 |
Millennium Management
New York
|
+$15.8K |
| 5 |
Renaissance Technologies
New York
|
+$14.6K |
Top Sellers
| 1 | -$152K | |
| 2 | -$25.1K | |
| 3 | -$20.8K | |
| 4 |
RC
RBF Capital
San Francisco,
California
|
-$11K |
| 5 |
Goldman Sachs
New York
|
-$9.76K |